Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Zoll Medical

This article was originally published in The Gray Sheet

Executive Summary

External defibrillator manufacturer is working to expand the capabilities of its PD 1400 external defibrillator with a family of modules currently under development, Zoll President and CEO Rolf Stutz told the Hambrecht & Quist life sciences conference in San Francisco Jan. 12. The modules include a pulse oximeter, which is being developed with Nellcor, and the PD 1500, a semi- automatic, user-friendly portable resuscitation device geared toward the ambulance and pre-hospital market. Zoll's products were recently approved for sale in Japan, where they will be sold by Fukuda Denshi....
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT000097

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel